NCT03199313View on ClinicalTrials.gov

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 26, 2017

Primary Completion Date

December 16, 2017

Study Completion Date

December 16, 2017

Conditions
TuberculosisTuberculosis, Pulmonary
Interventions
DRUG

Sutezolid

Sutezolid supplied as tablets and matching placebo for oral administration.

DRUG

Placebo

Matching Sutezolid placebo

Trial Locations (1)

78217

Worldwide Clinical Trials, San Antonio

All Listed Sponsors
lead

Global Alliance for TB Drug Development

OTHER

NCT03199313 - Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid | Biotech Hunter | Biotech Hunter